These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 322921)

  • 1. Clinical and cardiovascular effects of alpha methyldopa in combination with decarboxylase inhibitors.
    Kersting F; Reid JL; Dollery CT
    Clin Pharmacol Ther; 1977 May; 21(5):547-55. PubMed ID: 322921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the decarboxylase inhibitor benserazide on the antihypertensive effect and metabolism of alpha-methyldopa in patients with essential hypertension.
    Planz G; Gierlichs HW; Hawlina A; Planz R; Stephany W; Rahn KH
    Eur J Clin Pharmacol; 1977 Dec; 12(4):241-5. PubMed ID: 338308
    [No Abstract]   [Full Text] [Related]  

  • 3. Site of action of methyldopa in lowering the blood pressure in man.
    Kersting F; Reid JL; Dollery CT
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():11-5. PubMed ID: 277299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of desmethylimipramine on the pharmacological actions of alpha methyldopa in man.
    Reid JL; Porsius AJ; Zamboulis C; Polak G; Hamilton CA; Dean CR
    Eur J Clin Pharmacol; 1979 Sep; 16(2):75-80. PubMed ID: 499311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a predominantly central hypotensive effect of alpha-methyldopa in humans.
    Bobik A; Jennings G; Jackman G; Oddie C; Korner P
    Hypertension; 1986 Jan; 8(1):16-23. PubMed ID: 3943883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of trimazosin and methyldopa in hypertension.
    Aronow WS; Tobis J; Hughes D; Siegel J; Easthope J
    Clin Pharmacol Ther; 1977 Oct; 22(4):425-9. PubMed ID: 332438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of central and peripheral mechanisms in the action of alpha-methyldopa on blood pressure and renin secretion.
    Frankel RJ; Reid IA; Ganong WF
    J Pharmacol Exp Ther; 1977 May; 201(2):400-5. PubMed ID: 323462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pindolol and methyldopa on blood pressure and plasma norepinephrine.
    Winer N; Carter CH; Eddy H
    Am Heart J; 1982 Aug; 104(2 Pt 2):425-31. PubMed ID: 7048879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of metoprolol and alpha-methyldopa in untreated essential hypertension.
    Bergstrand RH; Vedin JA; Wilhelmsson CE; Berglund G
    Eur J Clin Pharmacol; 1976; 10(6):375-9. PubMed ID: 793848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central inhibitory effect of alpha-methyldopa on blood pressure, heart rate and body temperature of renal hypertensive rats.
    Nijkamp FP; Ezer J; De Jong W
    Eur J Pharmacol; 1975 Apr; 31(2):243-9. PubMed ID: 1149791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.
    Pinder RM; Brogden RN; Sawyer PR; Speight TM; Avery GS
    Drugs; 1976; 11(5):329-77. PubMed ID: 782834
    [No Abstract]   [Full Text] [Related]  

  • 12. Dose-titrated, double-blind, cross-over comparison of a selective beta-blocker and methyldopa in the treatment of hypertension.
    Routledge PA; Zrinzo LV; Rao JG; Walden RJ; Davies DM; Rawlins MD
    Eur J Clin Pharmacol; 1977 Mar; 11(3):159-62. PubMed ID: 323023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of oxprenolol and methyldopa in hypertension. A within-patient double-blind trial.
    Barritt DW; Marshall AJ; Heaton S
    Lancet; 1976 Mar; 1(7958):503-5. PubMed ID: 55780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The plasma noradrenaline and growth hormone response to alpha-methyldopa and clonidine in hypertensive subjects.
    Struthers AD; Brown MJ; Adams EF; Dollery CT
    Br J Clin Pharmacol; 1985 Mar; 19(3):311-7. PubMed ID: 3986086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combined use of L-alpha-methyldopa hydrazine and methyldopa in the treatment of hypertension.
    Louis WJ; Vajda FJ; McNeil JJ; Doyle AE; Jarrott B
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():17-22. PubMed ID: 354826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of an antihypertensive agent. Comparison of methyldopa and hydrochlorothiazide in combination and singly.
    McMahon FG
    JAMA; 1975 Jan; 231(2):155-8. PubMed ID: 1088916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of L-dopa and alpha-methyldopa on reflexes and sympathetic nerve function.
    Antonaccio MJ; Robson RD; Burrell R
    Eur J Pharmacol; 1974 Jan; 25(1):9-18. PubMed ID: 4435015
    [No Abstract]   [Full Text] [Related]  

  • 18. [The combination of methyldopa with pindolol in the treatment of hypertension (author's transl)].
    Szám I; Pálossy B
    MMW Munch Med Wochenschr; 1978 Dec; 120(51-52):1719-22. PubMed ID: 105251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive activity of alpha-methyldopa on a twice daily regimen in comparison to metoprolol. A multi-centre controlled clinical trial.
    Muiesan G; Agabiti-Rosei E; Alicandri C; Motolese M
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():35-41. PubMed ID: 354827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antihypertensive therapy on cardiovascular response to exercise.
    Lee WR; Fox LM; Slotkoff LM
    Am J Cardiol; 1979 Aug; 44(2):325-8. PubMed ID: 463771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.